CAS 144481-98-1
:Landiolol hydrochloride
Description:
Landiolol hydrochloride is a selective beta-1 adrenergic antagonist primarily used in clinical settings for its rapid onset and short duration of action, making it suitable for managing acute tachycardia and hypertension. It is a synthetic compound characterized by its ability to effectively lower heart rate and myocardial oxygen demand without significantly affecting peripheral vascular resistance. The substance is typically administered intravenously, allowing for precise control over dosing and immediate therapeutic effects. Its pharmacokinetic profile includes a rapid distribution phase and a short half-life, which necessitates continuous infusion for sustained effects. Landiolol hydrochloride is generally well-tolerated, with a side effect profile that may include hypotension and bradycardia. As with other beta-blockers, caution is advised in patients with pre-existing respiratory conditions or heart block. The compound's chemical structure features a unique arrangement that contributes to its selectivity and efficacy, making it a valuable tool in acute cardiovascular management.
Formula:C25H39N3O8·ClH
InChI:InChI=1S/C25H39N3O8.ClH/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28;/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31);1H/t20-,22+;/m0./s1
InChI key:InChIKey=DLPGJHSONYLBKP-IKGOIYPNSA-N
SMILES:C(CC(OC[C@H]1OC(C)(C)OC1)=O)C2=CC=C(OC[C@H](CNCCNC(=O)N3CCOCC3)O)C=C2.Cl
Synonyms:- Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, hydrochloride (1:1)
- Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, monohydrochloride
- Benzenepropanoic acid, 4-[2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl ester, monohydrochloride, [S-(R*,R*)]-
- Corebeta
- ONO 1101 hydrochloride
- Onoact
- Rapibloc
- [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-{[(2S)-2-hydroxy-3-({2-[(morpholin-4-ylcarbonyl)amino]ethyl}amino)propyl]oxy}phenyl)propanoate hydrochloride (1:1)
- [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate hydrochloride
- Landiolol hydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Benzenepropanoic acid, 4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester, hydrochloride (1:1)
CAS:Formula:C25H40ClN3O8Purity:98%Color and Shape:SolidMolecular weight:546.0534Landiolol hydrochloride
CAS:<p>Landiolol hydrochloride (ONO-1101 hydrochloride) is an ultra-short-acting β1 selective adrenoceptor antagonist.</p>Formula:C25H40ClN3O8Purity:99.91%Color and Shape:White Crystalline PowderMolecular weight:546.05Landiolol Hydrochloride
CAS:Controlled Product<p>Applications Landiolol is an ultra-short acting beta blocker that is used to treat patients with cardiac arrhythmias and is also used to treat tachycardia during anasthesia.<br>References Atarashi, H., et al.: Clin. Pharmacol. Ther., 68, 143 (2000); Harasawa, R., et al.: J. Cardiothor. Vasc. An., 20, 793 (2006);<br></p>Formula:C25H39N3O8·ClHColor and Shape:NeatMolecular weight:546.05((S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHYL 3-(4-((S)-2-HYDROXY-3-((2-(MORPHOLINE-4-CARBOXAMIDO)ETHYL)AMINO)PROPOXY)PHENYL)PROPANOATE HCL
CAS:Purity:97%Molecular weight:546.0599975585938Landiolol Hydrochloride
CAS:Formula:C25H39N3O8·HClPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:546.06






